A Prospective Clinical Investigation of DMFI300 for Treating Nasolabial Folds
Recruiting
N/A
Interventional Study
Nasolabial Folds, Wrinkles
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Samyang Biopharmaceuticals Corporation · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective, randomized, controlled clinical investigation designed to evaluate the performance and safety of DMFI300 for the treatment of nasolabial folds. 30 adult participants will receive treatment with the investigational device and the comparator device using a split-face design. The study will assess wrinkle severity using validated aesthetic evaluation scales, as well as overall …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men and women aged 18-70 years.
* Score of 3 to 4 on the Wrinkle Severity Rating Scale (WSRS) for both nasolabial folds.
* Willing and able to provide written informed consent.
* Willing to comply with study procedures and follow-up visits.
* Willing to refrain from other faci…
Contacts
No contact information available.